EGFR and pancreatic neoplasm: As indicated in Table 2, a significantly higher incidence of high expression of both EGFR and HAb18G/CD147 was found in pancreatic cancer tissues compared with normal tissues (71.57% [73/102] vs. 17.02% [8/47], P < 0.001).